TEMPE, Ariz., Nov. 17, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (the “Company”) (Nasdaq:CAPS) today announced that its application to transfer the listing of its common stock from The Nasdaq Global Market to The Nasdaq Capital Market has been approved by Nasdaq. This transfer will be effective at the opening of business on Friday, November 20, 2009, and the Company’s common stock will continue to trade under the symbol “CAPS.” The Nasdaq Capital Market is a continuous trading market that operates in substantially the same manner as The Nasdaq Global Market. All companies listed on The Nasdaq Capital Market must meet certain financial requirements and comply with Nasdaq’s corporate governance requirements.
